Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance
Stock Information for Fractyl Health, Inc.
Loading
Please wait while we load your information from QuoteMedia.